Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 4, 2012, Pages 439-441

  O'Toole, Aoibhlinn ^a   Alakkari, Alaa ^a   Keegan, Denise ^a   Doherty, Glen ^a   Mulcahy, Hugh ^a   O'Donoghue, Diarmuid ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Crohn's disease; Inflammatory bowel disease; Primary sclerosing cholangitis; Ulcerative colitis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COLITIS; CROHN DISEASE; DISEASE ACTIVITY; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIMARY SCLEROSING CHOLANGITIS; SCHOOL CHILD; SMALL INTESTINE DISEASE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHOLANGITIS, SCLEROSING; COLON; FEMALE; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; INTESTINE, SMALL; IRELAND; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84858705541     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.11.010     Document Type: Article

References (15)

1. Lee Y.M., Kaplan M.M. Primary sclerosing cholangitis. N Engl J Med 1995, 332:924-933.
2. Weismüller T.J., Wedemeyer J., Kubicka S., et al. The challenges in primary sclerosing cholangitis-aetiopathogenesis, autoimmunity, management and malignancy. J Hepatol 2008, 48(Suppl 1):S38-S57.
3. O'Mahony C.A., Vierling J.M. Etiopathogenesis of primary sclerosing cholangitis. Semin Liver Dis 2006, 26:3-21.
4. Woolf G.M., Vierling J.M. Disappearing intrahepatic bile ducts: the syndromes and their mechanisms. Semin Liver Dis 1993, 13:261-275.
5. Das K.M., Vecchi M., Sakamaki S. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. Gastroenterology 1990, 98:464-469.
6. Karlsen T.H., Hampe J., Wiencke K., et al. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Am J Gastroenterol 2007, 102:115-121.
7. Befeler A.S., Lissoos T.W., Schiano T.D., et al. Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation 1998, 65:393-396.
8. Hao W.L., Lee Y.K. Microflora of the gastrointestinal tract: a review. Methods Mol Biol 2004, 268:491-502.
9. Cullen G., Keegan D., Mulcahy H.E., et al. A 5-year prospective observational study of the outcomes of international treatment guidelines for Crohn's disease. Clin Gastroenterol Hepatol 2009, 7:323-328. quiz, 252.
10. Olsson R., Danielsson A., Järnerot G., et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991, 100:1319-1323.
11. Rasmussen H.H., Fallingborg J.F., Mortensen P.B., et al. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease. Scand J Gastroenterol 1997, 32:604-610.
12. Marelli L., Xirouchakis E., Kalambokis G., et al. Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?. Gut 2011, 60:1224-1228.
13. Eisen G.M. Endoscopic databases and outcomes research. Gastrointest Endosc Clin N Am 1999, 9:587-594. vi.
14. Hogan W.R., Wagner M.M. Accuracy of data in computer-based patient records. J Am Med Inform Assoc 1997, 4:342-355.
15. Cholongitas E., Shusang V., Papatheodoridis G.V., et al. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transplant 2008, 14:138-143.